Author:
Chao Angel,Lin Chiao-Yun,Wu Ren-Chin,Lee Yun-Shien,Lee Li-Yu,Tsai Chia-Lung,Yang Lan-Yan,Liu Hsuan,Chen Shu-Jen,Wang Tzu-Hao,Lai Chyong-Huey
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Drug Discovery,Molecular Medicine
Reference44 articles.
1. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL et al (2017) Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 1:109(9)
2. Cancer Registry Annual Report, 2014 Taiwan: Ministry of Health and Welfare, Executive Yuan 2016 https://www.hpa.gov.tw/BHPNet/English/Index.aspx
3. Creasman WT, Miller DS (2012) Adenocarcinoma of the uterine corpus. In: Di Saia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG (eds) Clinical gynecologic oncology. Elsevier, Philadelphia, pp 121–154
4. Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol 8:261–271
5. Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, Ellenson LH (2006) PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res 12:5932–5935
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献